HomeMYNDF • OTCMKTS
add
MYND Life Sciences Inc
Previous close
$0.068
Year range
$0.013 - $0.068
Market cap
2.13M CAD
Avg Volume
274.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 238.50K | 9.10% |
Net income | -379.27K | 28.54% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -341.69K | -8.97% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 497.00 | 188.95% |
Total assets | 719.72K | 110.68% |
Total liabilities | 6.71M | 15.45% |
Total equity | -5.99M | — |
Shares outstanding | 47.82M | — |
Price to book | -0.52 | — |
Return on assets | -119.70% | — |
Return on capital | 30.52% | — |
Cash Flow
Net change in cash
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Net income | -379.27K | 28.54% |
Cash from operations | -1.25K | 97.53% |
Cash from investing | -57.00 | — |
Cash from financing | — | — |
Net change in cash | -1.31K | -59.56% |
Free cash flow | 242.22K | 912.42% |
About
Founded
2018
Headquarters
Website
Employees
10
